1921
Volume 92, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Clinical characteristics and outcome among dengue patients with and without human immunodeficiency virus (HIV) infection remain elusive. A total of 10 dengue virus (DENV)–HIV Chinese patients were compared with 40 Chinese dengue patients without HIV, who were matched for age, gender, type of care received, methods, and year of dengue diagnosis from 2005 to 2008. Univariate and multivariate conditional logistics regression were applied. DENV-HIV patients were significantly associated with the World Health Organization (WHO) 2009 severe dengue (conditional odds ratio [COR] = 5.72; 95% confidence interval [CI] = 1.01–32.64) but not with the WHO 1997 dengue hemorrhagic fever/dengue shock syndrome (COR = 0.40; 95% CI = 0.09–1.71). This is mainly due to severe plasma leakage and the lack of hemorrhagic manifestations. Hospitalization duration was longer for DENV-HIV patients (10.5 days; interquartile range [IQR] = 5.5–26.3 days) compared with dengue patients (5 days; IQR = 4–6 days). There were no significant differences in presentation of clinical warning signs and symptoms at admission and during hospitalization, except for rash (adjusted COR [ACOR] = 0.06; 95% CI = 0.03–0.92). DENV-HIV patients were associated with higher pulse rate (ACOR = 1.13; 95% CI = 1.02–1.25), eosinophils proportion (ACOR = 3.07; 95% CI = 1.12–8.41) and lower hematocrit level (ACOR = 0.79; 95% CI = 0.64–0.98) compared with dengue patients. Even though DENV-HIV patients may present similarly to dengue patients, they may be more likely to have severe dengue outcome. Hence, close monitoring of DENV-HIV patients is highly recommended as part of dengue clinical care and management.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.15-0031
2015-06-03
2017-11-20
Loading full text...

Full text loading...

/deliver/fulltext/14761645/92/6/1156.html?itemId=/content/journals/10.4269/ajtmh.15-0031&mimeType=html&fmt=ahah

References

  1. Coker RJ, Hunter BM, Rudge JW, Liverani M, Hanvoravongchai P, , 2011. Emerging infectious diseases in southeast Asia: regional challenges to control. Lancet 377: 599609.[Crossref]
  2. John TJ, Dandona L, Sharma VP, Kakkar M, , 2011. Continuing challenge of infectious diseases in India. Lancet 377: 252269.[Crossref]
  3. Simon V, Ho DD, Abdool Karim Q, , 2006. HIV/AIDS epidemiology, pathogenesis, prevention, and treatment. Lancet 368: 489504.[Crossref]
  4. Mendes W da S, Branco M dos R, Medeiros MN, , 2006. Clinical case report: dengue hemorrhagic fever in a patient with acquired immunodeficiency syndrome. Am J Trop Med Hyg 74: 905907.
  5. Watt G, Kantipong P, Jongsakul K, , 2003. Decrease in human immunodeficiency virus type 1 load during acute dengue fever. Clin Infect Dis 36: 10671069.[Crossref]
  6. Gonzalez D, Limonta D, Bandera JF, Perez J, Kouri G, Guzman MG, , 2009. Dual infection with dengue virus 3 and human immunodeficiency virus 1 in Havana, Cuba. J Infect Dev Ctries 3: 318320.
  7. Siong WC, Ching TH, Jong GC, Pang CS, Vernon LJ, Sin LY, , 2008. Dengue infections in HIV patients. Southeast Asian J Trop Med Public Health 39: 260265.
  8. McLinden JH, Stapleton JT, Chang Q, Xiang J, , 2008. Expression of the dengue virus type 2 NS5 protein in a CD4(+) T cell line inhibits HIV replication. J Infect Dis 198: 860863.[Crossref]
  9. Xiang J, McLinden JH, Rydze RA, Chang Q, Kaufman TM, Klinzman D, Stapleton JT, , 2009. Viruses within the Flaviviridae decrease CD4 expression and inhibit HIV replication in human CD4+ cells. J Immunol 183: 78607869.[Crossref]
  10. Ooi EE, Goh KT, Gubler DJ, , 2006. Dengue prevention and 35 years of vector control in Singapore. Emerg Infect Dis 12: 887893.[Crossref]
  11. Sen P, Chio MT, Tan HH, Chan RK, , 2006. Rising trends of STIs and HIV infection in Singapore—a review of epidemiology over the last 10 years (1994 to 2003). Ann Acad Med Singapore 35: 229235.
  12. Gan VC, Lye DC, Thein TL, Dimatatac F, Tan AS, Leo YS, , 2013. Implications of discordance in World Health Organization 1997 and 2009 dengue classifications in adult dengue. PLoS ONE 8: e60946.[Crossref]
  13. Cutter JL, Lim WY, Ang LW, Tun Y, James L, Chew SK, , 2004. HIV in Singapore—past, present, and future. AIDS Educ Prev 16: 110118.[Crossref]
  14. Lee KS, Lai YL, Lo S, Barkham T, Aw P, Ooi PL, Tai JC, Hibberd M, Johansson P, Khoo SP, Ng LC, , 2010. Dengue virus surveillance for early warning, Singapore. Emerg Infect Dis 16: 847849.[Crossref]
  15. WHO, 1997. Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control, 2nd Ed. Geneva, Switzerland: World Health Organization.
  16. WHO, 2009. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control. Geneva, Switzerland: World Health Organization.
  17. Ministry of Health Singapore, 2013. Update on the HIV/AIDS Situation in Singapore 2013. Available at: http://www.moh.gov.sg/content/moh_web/home/statistics/infectiousDiseasesStatistics/HIV_Stats.html. Accessed March 1, 2015.
  18. Gonzalez-Duarte A, Sullivan S, Sips GJ, Naidich T, Kleinman G, Murray J, Morgello S, Germano I, Mullen M, Simpson D, , 2009. Inflammatory pseudotumor associated with HIV, JCV, and immune reconstitution syndrome. Neurology 72: 289290.[Crossref]
  19. Pang J, Salim A, Lee VJ, Hibberd ML, Chia KS, Leo YS, Lye DC, , 2012. Diabetes with hypertension as risk factors for adult dengue hemorrhagic fever in a predominantly dengue serotype 2 epidemic: a case control study. PLoS Negl Trop Dis 6: e1641.[Crossref]
  20. Taraphdar D, Sarkar A, Mukhopadhyay BB, Chatterjee S, , 2012. A comparative study of clinical features between monotypic and dual infection cases with chikungunya virus and dengue virus in West Bengal, India. Am J Trop Med Hyg 86: 720723.[Crossref]
  21. Sivaram M, White A, Radcliffe KW, , 2012. Eosinophilia: clinical significance in HIV-infected individuals. Int J STD AIDS 23: 635638.[Crossref]
  22. Cohen AJ, Steigbigel RT, , 1996. Eosinophilia in patients infected with human immunodeficiency virus. J Infect Dis 174: 615618.[Crossref]
  23. Colebunders R, Van Den Eynde C, Tolo A, Fleerackers Y, Vanham G, Kestens L, Vervoort T, Depraetere K, , 1997. Eosinophilia in patients infected with human immunodeficiency virus. J Infect Dis 175: 1283.[Crossref]
  24. Caterino-de-Araujo A, , 1994. HIV-1 infection and eosinophilia. Immunol Today 15: 498499.[Crossref]
  25. Chorba TL, Nkengasong J, Roels TH, Monga B, Maurice C, Maran M, Djomand G, , 2002. Assessing eosinophil count as a marker of immune activation among human immunodeficiency virus-infected persons in sub-Saharan Africa. Clin Infect Dis 34: 12641266.[Crossref]
  26. Wells RA, Scott RM, Pavanand K, Sathitsathein V, Cheamudon U, Macdermott RP, , 1980. Kinetics of peripheral blood leukocyte alterations in Thai children with dengue hemorrhagic fever. Infect Immun 28: 428433.
  27. Butthep P, Bunyaratvej A, Bhamarapravati N, , 1993. Dengue virus and endothelial cell: a related phenomenon to thrombocytopenia and granulocytopenia in dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health 24 (Suppl 1): 246249.
  28. Pang J, Thein TL, Leo YS, Lye DC, , 2014. Early clinical and laboratory risk factors of intensive care unit requirement during 2004–2008 dengue epidemics in Singapore: a matched case–control study. BMC Infect Dis 14: 649.[Crossref]
  29. Ong A, Sandar M, Chen MI, Sin LY, , 2007. Fatal dengue hemorrhagic fever in adults during a dengue epidemic in Singapore. Int J Infect Dis 11: 263267.[Crossref]
  30. See KC, Phua J, Yip HS, Yeo LL, Lim TK, , 2013. Identification of concurrent bacterial infection in adult patients with dengue. Am J Trop Med Hyg 89: 804810.[Crossref]
  31. Phe T, Thai S, Veng C, Sok S, Lynen L, van Griensven J, , 2013. Risk factors of treatment-limiting anemia after substitution of zidovudine for stavudine in HIV-infected adult patients on antiretroviral treatment. PLoS ONE 8: e60206.[Crossref]
  32. Sulkowski MS, Chaisson RE, Karp CL, Moore RD, Margolick JB, Quinn TC, , 1998. The effect of acute infectious illnesses on plasma human immunodeficiency virus (HIV) type 1 load and the expression of serologic markers of immune activation among HIV-infected adults. J Infect Dis 178: 16421648.[Crossref]
  33. Hoffman IF, Jere CS, Taylor TE, Munthali P, Dyer JR, Wirima JJ, Rogerson SJ, Kumwenda N, Eron JJ, Fiscus SA, Chakraborty H, Taha TE, Cohen MS, Molyneux ME, , 1999. The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration. AIDS 13: 487494.[Crossref]
  34. Alvar J, Canavate C, Gutierrez-Solar B, Jimenez M, Laguna F, Lopez-Velez R, Molina R, Moreno J, , 1997. Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin Microbiol Rev 10: 298319.
  35. Rocha A, de Meneses AC, da Silva AM, Ferreira MS, Nishioka SA, Burgarelli MK, Almeida E, Turcato Junior G, Metze K, Lopes ER, , 1994. Pathology of patients with Chagas' disease and acquired immunodeficiency syndrome. Am J Trop Med Hyg 50: 261268.
  36. Mole L, Ripich S, Margolis D, Holodniy M, , 1997. The impact of active herpes simplex virus infection on human immunodeficiency virus load. J Infect Dis 176: 766770.[Crossref]
  37. Watt G, Kantipong P, de Souza M, Chanbancherd P, Jongsakul K, Ruangweerayud R, Loomis-Price LD, Polonis V, Myint KS, Birx DL, Brown AE, Krishna S, , 2000. HIV-1 suppression during acute scrub-typhus infection. Lancet 356: 475479.[Crossref]
  38. Moss WJ, Scott S, Ndhlovu Z, Monze M, Cutts FT, Quinn TC, Griffin DE, , 2009. Suppression of human immunodeficiency virus type 1 viral load during acute measles. Pediatr Infect Dis J 28: 6365.[Crossref]
  39. Tillmann HL, Heiken H, Knapik-Botor A, Heringlake S, Ockenga J, Wilber JC, Goergen B, Detmer J, McMorrow M, Stoll M, Schmidt RE, Manns MP, , 2001. Infection with GB virus C and reduced mortality among HIV-infected patients. N Engl J Med 345: 715724.[Crossref]
  40. Xiang J, Wunschmann S, Diekema DJ, Klinzman D, Patrick KD, George SL, Stapleton JT, , 2001. Effect of coinfection with GB virus C on survival among patients with HIV infection. N Engl J Med 345: 707714.[Crossref]
  41. Xiang J, McLinden JH, Chang Q, Kaufman TM, Stapleton JT, , 2006. An 85-aa segment of the GB virus type C NS5A phosphoprotein inhibits HIV-1 replication in CD4+ Jurkat T cells. Proc Natl Acad Sci USA 103: 1557015575.[Crossref]
  42. Magalhaes BM, Siqueira AM, Alexandre MA, Souza MS, Gimaque JB, Bastos MS, Figueiredo RM, Melo GC, Lacerda MV, Mourao MP, , 2014. P. vivax malaria and dengue fever co-infection: a cross-sectional study in the Brazilian Amazon. PLoS Negl Trop Dis 8: e3239.[Crossref]
  43. Assir MZ, Masood MA, Ahmad HI, , 2014. Concurrent dengue and malaria infection in Lahore, Pakistan during the 2012 dengue outbreak. Int J Infect Dis 18: 4146.[Crossref]
  44. Epelboin L, Hanf M, Dussart P, Ouar-Epelboin S, Djossou F, Nacher M, Carme B, , 2012. Is dengue and malaria co-infection more severe than single infections? A retrospective matched-pair study in French Guiana. Malar J 11: 142.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.15-0031
Loading
/content/journals/10.4269/ajtmh.15-0031
Loading

Data & Media loading...

Supplementary Data

Supplementary PDF

  • Received : 14 Jan 2015
  • Accepted : 02 Mar 2015

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error